SinuSys Corporation Announces FDA Clearance of its Sinus Dilation System

SinuSys Corporation, a sinus health company, announced that it has received clearance from the U.S. Food and Drug Administration for its Vent-Os Sinus Dilation System, which is designed to resolve sinusitis symptoms in a two-step interventional procedure.

The device enables low-pressure, gradual dilation of the maxillary sinus ostia, which is intended to help patients tolerate the procedure in an office setting under local anesthesia.

The Vent-Os system has also received the CE Mark, Health Canada license and Australian Therapeutic Goods Administration Certificate.

More Articles on Supply Chain:

Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers